[Effect of methylguanidine and guanidine succinic acid on methemoglobin reductase activity in human red cells].
Activity of methemoglobin reductase was studied in human red cells treated with methylguanidine and guanidinosuccinic acid in concentrations similar to those in plasma of patients with chronic renal failure. Enzyme activity was measured with Richterich technique following an incubation at 37 degrees C for three hours. Results have shown that methylguanidine in concentration of 5.4 x 10(-5) mol/l decreases activity of methemoglobin reductase in human red cells on average by 13.9%. Higher concentrations potentiate this effect. Similar changes in methemoglobin reductase activity were noted after introduction of guanidine-succinic acid into the mixture. This agent in concentration 5.6 x 10(-5) mol/l inhibited activity of the tested enzyme by 34.2% on average. Combined methylguanidine in concentration of 5.4 x 10(-5) mol/l and guanidine-succinic acid in concentration of 2.8 x 10(-5) mol/l inhibited methemoglobin reductase activity by 33.0% on average. It may be suggested, that methylguanidine and guanidine-succinic acid being low molecular uremic toxins may significantly decrease methemoglobin reductase activity in red cells of patients with chronic renal failure.
Kopczyński
Z
Z
Zakładu Analityki Medycznej Katedry Onkologii Akademii Medycznej im. Karola Marcinkowskiego, Poznaniu.
Dryl-Rydzyńska
T
T
D000328:Adult; D042966:Cytochrome-B(5) Reductase / Q000378:metabolism*; D004912:Erythrocytes / Q000187:drug effects* / Q000201:enzymology; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008760:Methylguanidine / Q000494:pharmacology*; D013386:Succinates / Q000494:pharmacology*
D006146:Guanidines; D013386:Succinates; D008760:Methylguanidine; C001318:guanidinosuccinic acid; D042966:Cytochrome-B(5) Reductase
Wpływ metyloguanidyny i kwasu guanidynobursztynowego na aktywność reduktazy methemoglobiny krwinek czerwonych człowieka.